Showing results (261-270 of 432) with videos related to
Sort By:
Pageof 44
Medicine|June 9, 2021
Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2Hèctor Corominas, Ivan Castellví, César Diaz-Torné, et al.Frontiers in Immunology|November 26, 2020
Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected SubjectsIsaac Rosado-Sánchez, Rebeca De Pablo-Bernal, Anna Rull, et al.Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.Plos One|December 31, 2015
Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based CohortCésar Garriga, Patricia García de Olalla, Josep M Miró, et al.AIDS Research and Therapy|July 7, 2011
Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009Patricia Garcia de Olalla, Christian Manzardo, Maria A Sambeat, et al.Molecular Genetics and Metabolism|April 11, 2006
Altered expression of master regulatory genes of adipogenesis in lipomas from patients bearing tRNA(Lys) point mutations in mitochondrial DNAJordi P Guallar, Maya R Vilà, Ester López-Gallardo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter studyVicenç Falcó, Montserrat Olmo, Sara Villar del Saz, et al.Journal of Neurology|April 30, 2022
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptomsMarco Calabria, Carmen García-Sánchez, Nicholas Grunden, et al.The Journal of Antimicrobial Chemotherapy|August 2, 2020
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular diseaseAna Gonzalez-Cordon, Lambert Assoumou, Miguel Camafort, et al.Ebiomedicine|March 19, 2019
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infectionLaura Tarancon-Diez, Esther Rodríguez-Gallego, Anna Rull, et al.Pageof 44